SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-013411
Filing Date
2022-07-29
Accepted
2022-07-28 18:17:44
Documents
71
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rare-20220630.htm   iXBRL 10-Q 3489597
2 EX-10.1 rare-ex10_1.htm EX-10.1 530277
3 EX-10.2 rare-ex10_2.htm EX-10.2 1178437
4 EX-31.1 rare-ex31_1.htm EX-31.1 19244
5 EX-31.2 rare-ex31_2.htm EX-31.2 19245
6 EX-32.1 rare-ex32_1.htm EX-32.1 15486
7 GRAPHIC img215004588_0.jpg GRAPHIC 198380
  Complete submission text file 0000950170-22-013411.txt   12724550

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rare-20220630_cal.xml EX-101.CAL 46854
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rare-20220630_pre.xml EX-101.PRE 309472
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rare-20220630_def.xml EX-101.DEF 184894
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rare-20220630.xsd EX-101.SCH 64198
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rare-20220630_lab.xml EX-101.LAB 411064
65 EXTRACTED XBRL INSTANCE DOCUMENT rare-20220630_htm.xml XML 2029025
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 221116640
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences